Abstract:Purpose Inpatient glycemic management has become a common issue because of the increasing number of hospitalized patients with hyperglycemia. Point-of-care devices can enable timely inpatient glucose monitoring, which may lead to better outcomes. The accuracy of point-of-care testing in various clinical scenarios has been questioned, particularly in neonates and critically ill patients. This study aimed to evaluate the accuracy of the CONTOUR PLUS and CONTOUR PLUS ONE glucometers (new wireless systems that link to a smart mobile device) when used as point-of-care devices for blood glucose monitoring in neonates and critically ill adults in inpatient settings. Methods This cross-sectional study was conducted at a medical center in central Taiwan and enrolled patients admitted to the neonatal intensive care unit, sick child room, or respiratory intensive care unit between November 2020 and April 2021. Neonates with suspected infection or abnormal blood coagulation and adults who had abnormal blood coagulation, were pregnant, had received organ transplants, or had undergone massive blood transfusions were excluded. The accuracy of the glucometers was determined based on the following criteria of the International Organization for Standardization (ISO) standard: 15197:2013. Findings Overall, 114 neonates (mean age, 4.2 days [range, 0–28 days]; 65 boys [57.0%]) and 106 hospitalized critically ill adults (mean age, 68.2 years [range, 27–94 years]; 72 men [67.9%]) were enrolled in this study. The glucose values obtained with each glucometer had good precision, and all findings met the reference criteria of the within-lot results. All measurements of the neonates' venous blood by each glucometer met the accuracy criteria specified by ISO standard 15197:2013. Furthermore, 98.1% and 97.2% of the arterial blood glucose measurements for critically ill adults obtained with CONTOUR PLUS and CONTOUR PLUS ONE met the accuracy criteria, respectively. Implications Both glucose management systems met the accuracy criteria for venous blood from neonates and arterial blood from critically ill adults. Thus, the use of these 2 point-of-care devices in inpatient settings, including for neonates and critically ill adults, can be recommended to minimize limitations associated with the clinical application of point-of-care testing in glucose management. The wireless connection may play a role in the subsequent development of institution-wide virtual glycemic management under the supervision of a team of endocrinologists.

Validity of over the counter finger stick glucose measurement devices in comparison with laboratory venous plasma glucose measurements on pregnant women with diabetes

Evaluation of Blood Glucose Meter Efficacy in an Antenatal Diabetes Clinic

Assessing the Accuracy of Different Glucometers Based on the Laboratory Reference Method

Magnitude of Gestational Diabetes Mellitus, its Influencing Factors and Diagnostic Accuracy of Capillary Blood Testing for its Detection at a Tertiary Care Centre, Rajkot, Gujarat

Performance of point-of-care glucose testing for the diagnosis of gestational diabetes in South Africa

Assessment of glucose meter performance at the antenatal diabetes clinic: exploration of patient-related and pre-analytical factors

Use of capillary blood glucose for screening for gestational diabetes mellitus in resource-constrained settings

Capillary blood glucose screening for gestational diabetes: a preliminary investigation

Glucometer analysis of one-hour glucose challenge samples

Evaluation of point-of-care maternal glucose measurements for the diagnosis of gestational diabetes mellitus

Precision of office-based blood glucose meters in screening for gestational diabetes

Precision of reflectance meters in screening for gestational diabetes

Accuracy of Point-of-Care Blood Glucometers in Neonates and Critically Ill Adults

Evaluating the utility of a point-of-care glucometer for the diagnosis of gestational diabetes

Comparison of capillary Accu-Chek blood glucose values to laboratory values

Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes

A comparison between point-of-care testing and venous glucose determination for the diagnosis of diabetes mellitus 6-12 weeks after gestational diabetes

Clinical utility of point‐of‐care glucose testing in the assessment of gestational diabetes: Prospective cohort study

Diagnosis of gestational diabetes by capillary blood samples and a portable reflectance meter: derivation of threshold values and prospective validation

Assessment of the Performance of Blood Glucose Monitoring Systems for Monitoring Dysglycaemia in Neonatal Patients.

Capillary glucose concentration during oral glucose tolerance test for the diagnosis of gestational diabetes